Country Profile
Switzerland

When a company raises money, either an initial public offering or follow-up offering, the offering may include DRs. The inclusion of DRs may broaden the shareholder base of the company.

After the offering, BNY Mellon collects fees from DR holders pursuant to the terms and conditions of the DRs and the deposit agreement under which they are issued. From time to time,
BNY Mellon may make payments to the issuer to reimburse and / or share revenue from the fees collected from DR holders, or waive fees and expenses to the issuer for services provided, generally relating to costs and expenses arising out of establishment and maintenance of the DR program. BNY Mellon may also transact with affiliated brokers and dealers.

The DR Capital Raising Directory contains data for all related events since January 1, 2000.

Click any DR issue name below to view a comprehensive DR profile
Displaying 1 - 4 of 4

DR Issue Symbol CUSIP Ratio DR:Ord DR Exch DR Price Date DR Price(USD) US / Non-US / Total DRs Placed US / Non-US / Total DR Capital Raised (USD) Pvtzn. Dep. Bank Industry Country Region
Inficon
IFCN
45663T109
10:1 NASDAQ Stock Market
Nov 09, 2000 12.50 511,620
0
511,620
6,395,250
0
6,395,250
N BK Industrial Engineer. Switzerland Continental Europe
Merck Serono
SRA
81752M101
40:1 New York Stock Exchange
Jul 26, 2000 23.49 62,844,600
0
62,844,600
1,476,219,654
0
1,476,219,654
Y BK Pharma. & Biotech. Switzerland Continental Europe
SCOR Holding (Switzerland)
SCRJY
21248N107
2:1 OTC
Dec 11, 2001 24.59 7,808,100
0
7,808,100
192,001,179
0
192,001,179
N BK Nonlife Insurance Switzerland Continental Europe
Syngenta
SYT
87160A100
5:1 New York Stock Exchange
Nov 13, 2000 8.62 187,950
0
187,950
1,620,129
0
1,620,129
N BK Chemicals Switzerland Continental Europe

© 2014 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.